Etienne Giroux-Leprieur

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

K. Leroy, H. Blons, F. Goldwasser, 2020, Cancers.

Validity of Targeted Next-Generation Sequencing in Routine Care for Identifying Clinically Relevant Molecular Profiles in Non-Small-Cell Lung Cancer: Results of a 2-Year Experience on 1343 Samples.

P. Laurent-Puig, B. Rance, H. Blons, 2018, The Journal of molecular diagnostics : JMD.